Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Charmacy Pharmaceutical Co., Ltd. Board/Management Information 2017

Jul 19, 2017

50500_rns_2017-07-19_2a1aa597-76ef-4ab4-93dd-a88e9a768add.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [66 x 55] intentionally omitted <==

CHARMACY PHARMACEUTICAL CO., LTD. 創美藥業股份有限公司

(a joint stock limited liability company established in the People’s Republic of China)

List of directors and their roles and functions

Members of the board of directors (the “ Board ”) of Charmacy Pharmaceutical Co., Ltd. are set out below:

  • Mr. Yao Chuanglong (Chairman, Executive Director and Chief Executive Officer)

  • Ms. Zheng Yuyan (Vice President, Executive Director and Chief Marketing Officer)

  • Mr. Lin Zhixiong (Executive Director, Joint Company Secretary and Chief Financial Officer)

  • Ms. You Zeyan (Non-executive Director)

  • Mr. Li Weisheng (Non-executive Director)

  • Mr. Wan Chi Wai Anthony (Independent Non-executive Director)

  • Mr. Zhou Tao (Independent Non-executive Director)

  • Mr. Guan Jian (also known as Guan Suzhe) (Independent Non-executive Director)

The Board has established the Audit Committee, the Nomination Committee, the Remuneration Committee, the Strategic Development Committee and the Risk Management Committee and these committees are comprised of the following members:

Committee Members Audit Committee Mr. Wan Chi Wai Anthony (Chairman) Mr. Zhou Tao (Member) Mr. Guan Jian (Member) Nomination Committee Mr. Zhou Tao (Chairman) Mr. Yao Chuanglong (Member) Mr. Guan Jian (Member) Remuneration Committee Mr. Zhou Tao (Chairman) Mr. Wan Chi Wai Anthony (Member) Ms. You Zeyan (Member) Strategic Development Committee Mr. Yao Chuanglong (Chairman) Ms. Zheng Yuyan (Member) Mr. Zhou Tao (Member) Risk Management Committee Mr. Yao Chuanglong (Chairman) Mr. Lin Zhixiong (Member) Mr. Wan Chi Wai Anthony (Member) Hong Kong, 19 July 2017